1 study found for:    12001991 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: Melphalan;   Drug: Bortezomib;   Drug: Melphalan and bortezomib

Indicates status has not been verified in more than two years